Cyclacel Pharmaceuticals (CYCC)
Add to Watchlists Create an Alert
3.18
+0.19 +6.35%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Cyclacel Pharmaceuticals Revenue Quarterly YoY Growth
Cyclacel Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 30, 2012 | -13.10% |
| March 31, 2012 | -16.15% |
| Dec. 31, 2011 | |
| Sept. 30, 2011 | -100.0% |
| June 30, 2011 | 41.18% |
| March 31, 2011 | -29.15% |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | -30.87% |
| June 30, 2010 | -55.26% |
| March 31, 2010 | 18.86% |
| Dec. 31, 2009 | -25.50% |
| Sept. 30, 2009 | -14.50% |
| June 30, 2009 | 47.78% |
| March 31, 2009 | 28.81% |
| Dec. 31, 2008 | 1992% |
| Sept. 30, 2008 | 715.2% |
| June 30, 2008 | 480.6% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
CYCC Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| DARA Biosciences | |
| 3SBio | 18.51% |
| Exelixis | -47.76% |
CYCC Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -100.0% | Sep 2011 |
| Maximum | 1992% | Dec 2008 |
| Average | 202.6% |